Literature DB >> 6876181

Dantrolene sodium: effects on isolated cardiac tissues.

J J Salata, J A Wasserstrom, J Jalife.   

Abstract

The effects of dantrolene sodium on dog Purkinje fibers, cat atrial and ventricular muscles were studied. Action potential duration was significantly increased and contractility was significantly decreased by dantrolene in all three types of tissue. The plateau phase of Purkinje fiber and occasionally atrial action potential was slightly depressed. Dantrolene sodium had no significant effect on resting membrane potential, action potential amplitude or upstroke velocity of phase 6. The negative inotropic effects were most pronounced in Purkinje fibers, followed by atrial muscle while papillary muscles were least sensitive. Contractile force of Purkinje fibers was decreased by relatively the same amount at all frequencies of stimulation. At faster rates, atrial and ventricular muscle contractility was depressed relatively more than at slower rates. Slow response action potentials in cat papillary muscle were diminished slightly, but this effect was not significant. All drug effects took 10 to 15 min to develop, reached a steady state after 30 to 40 min, and were irreversible upon washout. Increasing the extracellular calcium concentration reversed the dantrolene-induced changes. These findings suggest that effects of dantrolene are mediated in part by a decrease in the intracellular free calcium concentration in cardiac tissue.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6876181     DOI: 10.1016/0022-2828(83)90278-x

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN: 0022-2828            Impact factor:   5.000


  5 in total

1.  Essential Role of Calmodulin in RyR Inhibition by Dantrolene.

Authors:  Ye Win Oo; Nieves Gomez-Hurtado; Kafa Walweel; Dirk F van Helden; Mohammad S Imtiaz; Bjorn C Knollmann; Derek R Laver
Journal:  Mol Pharmacol       Date:  2015-04-28       Impact factor: 4.436

Review 2.  Calcium antagonists. Drug interactions of clinical significance.

Authors:  T Rosenthal; D Ezra
Journal:  Drug Saf       Date:  1995-09       Impact factor: 5.606

Review 3.  Dantrolene. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in malignant hyperthermia, the neuroleptic malignant syndrome and an update of its use in muscle spasticity.

Authors:  A Ward; M O Chaffman; E M Sorkin
Journal:  Drugs       Date:  1986-08       Impact factor: 9.546

4.  Effects of dantrolene on arrhythmogenicity in isolated regional ischemia-reperfusion rabbit hearts with or without pacing-induced heart failure.

Authors:  Chung-Chuan Chou; Hui-Ling Lee; Po-Cheng Chang; Hung-Ta Wo; Ming-Shien Wen; San-Jou Yeh
Journal:  Biomed Res Int       Date:  2015-02-19       Impact factor: 3.411

5.  Atrial Infarction-Induced Spontaneous Focal Discharges and Atrial Fibrillation in Sheep: Role of Dantrolene-Sensitive Aberrant Ryanodine Receptor Calcium Release.

Authors:  Uma Mahesh R Avula; Jonathan J Hernandez; Masatoshi Yamazaki; Carmen R Valdivia; Antony Chu; Alvaro Rojas-Pena; Kuljeet Kaur; Roberto Ramos-Mondragón; Justus M Anumonwo; Stanley Nattel; Héctor H Valdivia; Jérôme Kalifa
Journal:  Circ Arrhythm Electrophysiol       Date:  2018-03
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.